Table II.
Demographics of matched cohorts
| Variable | Category | HCT treatment |
SMD | |
|---|---|---|---|---|
| No (%) |
Yes (%) |
|||
| 12,197 | 12,197 | |||
| Age (years, SD) | 77.68 (8.54) | 77.63 (8.36) | 0.006 | |
| Age | 60 to <70 y | 2440 (20.0) | 2423 (19.9) | 0.009 |
| 70 to <80 y | 4523 (37.1) | 4562 (37.4) | ||
| 80 to <90 y | 4291 (35.2) | 4293 (35.2) | ||
| 90 y and above | 943 (7.7) | 919 (7.5) | ||
| Sex | Men | 4908 (40.2) | 4901 (40.2) | 0.001 |
| Women | 7289 (59.8) | 7296 (59.8) | ||
| Comorbidities | ||||
| Cerebrovascular disease | Presence | 3490 (28.6) | 3559 (29.2) | 0.012 |
| Dementia | Presence | 1104 (9.1) | 1123 (9.2) | 0.005 |
| Myocardial infarction | Presence | 323 (2.6) | 365 (3.0) | 0.021 |
| Renal disease | Presence | 688 (5.6) | 754 (6.2) | 0.023 |
| Congestive heart failure | Presence | 3123 (25.6) | 3084 (25.3) | 0.007 |
| Peripheral vascular disease | Presence | 2068 (17.0) | 2074 (17.0) | 0.001 |
| Chronic pulmonary disease | Presence | 2996 (24.6) | 3007 (24.7) | 0.002 |
| Rheumatic disease | Presence | 413 (3.4) | 442 (3.6) | 0.013 |
| Peptic ulcer disease | Presence | 2398 (19.7) | 2392 (19.6) | 0.001 |
| Mild liver disease | Presence | 2068 (17.0) | 2151 (17.6) | 0.018 |
| Diabetes without chronic complication | Presence | 301 (2.5) | 349 (2.9) | 0.024 |
| Diabetes with chronic complication | Presence | 1100 (9.0) | 1097 (9.0) | 0.001 |
| Hemiplegia or paraplegia | Presence | 163 (1.3) | 183 (1.5) | 0.014 |
| Moderate or severe liver disease | Presence | 17 (0.1) | 25 (0.2) | 0.016 |
| Cardiac arrhythmias | Presence | 2311 (18.9) | 2342 (19.2) | 0.006 |
| Vulvar disease | Presence | 891 (7.3) | 934 (7.7) | 0.013 |
| Pulmonary circulation disorders | Presence | 29 (0.2) | 37 (0.3) | 0.013 |
| Hypertension, uncomplicated | Presence | 12,172 (99.8) | 12,167 (99.8) | 0.009 |
| Other neurological disorders | Presence | 539 (4.4) | 590 (4.8) | 0.02 |
| Diabetes, uncomplicated | Presence | 268 (2.2) | 313 (2.6) | 0.024 |
| Diabetes, complicated | Presence | 1108 (9.1) | 1108 (9.1) | <0.001 |
| Hypothyroidism | Presence | 323 (2.6) | 353 (2.9) | 0.015 |
| Renal failure | Presence | 686 (5.6) | 752 (6.2) | 0.023 |
| Liver disease | Presence | 2072 (17.0) | 2158 (17.7) | 0.019 |
| Peptic ulcer disease excluding bleeding | Presence | 2350 (19.3) | 2337 (19.2) | 0.003 |
| Rheumatoid arthritis/collagen vascular diseases | Presence | 506 (4.1) | 533 (4.4) | 0.011 |
| Coagulopathy | Presence | 150 (1.2) | 155 (1.3) | 0.004 |
| Obesity | Presence | 66 (0.5) | 75 (0.6) | 0.01 |
| Weight loss | Presence | 64 (0.5) | 74 (0.6) | 0.011 |
| Fluid and electrolyte disorders | Presence | 1574 (12.9) | 1624 (13.3) | 0.012 |
| Blood loss anemia | Presence | 26 (0.2) | 41 (0.3) | 0.024 |
| Deficiency anemia | Presence | 1289 (10.6) | 1292 (10.6) | 0.001 |
| Alcohol abuse | Presence | 68 (0.6) | 83 (0.7) | 0.016 |
| Drug abuse | Presence | 4 (0.0) | 4 (0.0) | <0.001 |
| Depression | Presence | 943 (7.7) | 1000 (8.2) | 0.017 |
| Psychoses | Presence | 293 (2.4) | 308 (2.5) | 0.008 |
| Medicine | ||||
| Ciclosporin | Taken | 8 (0.1) | 14 (0.1) | 0.016 |
| Methotrexate | Taken | 58 (0.5) | 69 (0.6) | 0.013 |
| Statins | Taken | 12,197 (100.0) | 12,197 (100.0) | <0.001 |
HCT, Hydrochlorothiazide; SMD, standardized mean difference.